BG Schimmelmann

1.1k total citations · 1 hit paper
11 papers, 803 citations indexed

About

BG Schimmelmann is a scholar working on Psychiatry and Mental health, Clinical Psychology and Social Psychology. According to data from OpenAlex, BG Schimmelmann has authored 11 papers receiving a total of 803 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Psychiatry and Mental health, 7 papers in Clinical Psychology and 3 papers in Social Psychology. Recurrent topics in BG Schimmelmann's work include Schizophrenia research and treatment (6 papers), Child and Adolescent Psychosocial and Emotional Development (4 papers) and Mental Health Treatment and Access (3 papers). BG Schimmelmann is often cited by papers focused on Schizophrenia research and treatment (6 papers), Child and Adolescent Psychosocial and Emotional Development (4 papers) and Mental Health Treatment and Access (3 papers). BG Schimmelmann collaborates with scholars based in Switzerland, Germany and Australia. BG Schimmelmann's co-authors include Martin Lambert, Frauke Schultze‐Lutter, Dieter Naber, Philippe Conus, Patrick D. McGorry, Darryl Wade, Hok Pan Yuen, Dan I. Lubman, Steffen Moritz and Anthony P. Morrison and has published in prestigious journals such as Schizophrenia Research, Acta Psychiatrica Scandinavica and European Psychiatry.

In The Last Decade

BG Schimmelmann

11 papers receiving 783 citations

Hit Papers

EPA guidance on the early intervention in clinical high r... 2015 2026 2018 2022 2015 100 200 300 400

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
BG Schimmelmann Switzerland 7 691 282 260 135 110 11 803
Marsha Tanenberg‐Karant United States 13 802 1.2× 356 1.3× 318 1.2× 158 1.2× 123 1.1× 18 993
Nikolai Albert Denmark 16 844 1.2× 308 1.1× 352 1.4× 195 1.4× 131 1.2× 40 1.0k
Adanna Onyejiaka United Kingdom 12 604 0.9× 277 1.0× 187 0.7× 150 1.1× 148 1.3× 15 826
F. Liraud France 14 894 1.3× 404 1.4× 330 1.3× 177 1.3× 137 1.2× 20 1.1k
Natalie Maples United States 17 982 1.4× 331 1.2× 298 1.1× 142 1.1× 198 1.8× 32 1.2k
James R. Luke United States 10 632 0.9× 188 0.7× 123 0.5× 75 0.6× 147 1.3× 10 800
Alison Blair United Kingdom 5 658 1.0× 275 1.0× 352 1.4× 103 0.8× 105 1.0× 10 810
Lakshmi P. Voruganti Canada 11 493 0.7× 183 0.6× 175 0.7× 129 1.0× 103 0.9× 15 653
Julie Evensen Norway 16 793 1.1× 319 1.1× 332 1.3× 147 1.1× 179 1.6× 32 961
Judith Rietdijk Netherlands 14 762 1.1× 368 1.3× 379 1.5× 168 1.2× 253 2.3× 21 945

Countries citing papers authored by BG Schimmelmann

Since Specialization
Citations

This map shows the geographic impact of BG Schimmelmann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by BG Schimmelmann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites BG Schimmelmann more than expected).

Fields of papers citing papers by BG Schimmelmann

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by BG Schimmelmann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by BG Schimmelmann. The network helps show where BG Schimmelmann may publish in the future.

Co-authorship network of co-authors of BG Schimmelmann

This figure shows the co-authorship network connecting the top 25 collaborators of BG Schimmelmann. A scholar is included among the top collaborators of BG Schimmelmann based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with BG Schimmelmann. BG Schimmelmann is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

11 of 11 papers shown
1.
2.
Groth, Nicola, Frauke Schultze‐Lutter, BG Schimmelmann, et al.. (2017). A naturalistic and prospective study on preventive interventions in children and adolescents at clinical high risk for psychosis. Open Access CRIS of the University of Bern. 1 indexed citations
3.
Schimmelmann, BG, et al.. (2017). What becomes of risk symptoms in the community? 2.5-year follow-up findings of the bern epidemiological at-risk (BEAR) study. Open Access CRIS of the University of Bern. 1 indexed citations
4.
Holtmann, Martin & BG Schimmelmann. (2016). From Psychopharmacological Evidence to Clinical Practice: Unmet Needs in Child & Adolescent Psychiatry – Reflections on Kölch & Plener. Pharmacopsychiatry. 49(6). 227–228. 1 indexed citations
5.
Schimmelmann, BG & Martin Holtmann. (2016). Early Intervention in Psychosis and Bipolar Disorder in Children and Adolescents – Reflections on Lambert, Niehaus and Correll. Pharmacopsychiatry. 49(6). 246–247. 1 indexed citations
6.
Schmidt, Stefanie J., Frauke Schultze‐Lutter, BG Schimmelmann, et al.. (2015). EPA guidance on the early intervention in clinical high risk states of psychoses. European Psychiatry. 30(3). 388–404. 408 indexed citations breakdown →
7.
Cotton, Sue, Martin Lambert, BG Schimmelmann, et al.. (2013). Differences between first episode schizophrenia and schizoaffective disorder. Schizophrenia Research. 147(1). 169–174. 19 indexed citations
8.
Schimmelmann, BG, et al.. (2011). Versorgungswege von erstmanifesten psychotischen Patienten – eine Übersicht internationaler Studien. Fortschritte der Neurologie · Psychiatrie. 80(2). 72–78. 19 indexed citations
9.
Lambert, Martin, BG Schimmelmann, Dieter Naber, et al.. (2009). Early- and Delayed Antipsychotic Response and Prediction of Outcome in 528 Severely Impaired Patients with Schizophrenia Treated with Amisulpride. Pharmacopsychiatry. 42(6). 277–283. 34 indexed citations
10.
Lambert, Martin, Philippe Conus, Dan I. Lubman, et al.. (2005). The impact of substance use disorders on clinical outcome in 643 patients with first‐episode psychosis. Acta Psychiatrica Scandinavica. 112(2). 141–148. 266 indexed citations
11.
Lambert, Martin, Philippe Conus, BG Schimmelmann, et al.. (2005). Comparison of Olanzapine and Risperidone in 367 First-Episode Patients with Non-Affective or Affective Psychosis: Results of an Open Retrospective Medical Record Study. Pharmacopsychiatry. 38(5). 206–213. 26 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026